The Chemours Company
NYSE:CC
$ 27.69
+ $0.37 (1.35%)
$ 27.69
+ $0.37 (1.35%)
End-of-day quote: 04/29/2024

CC - The Chemours Stock Prediction 2025 - 2030

9 years of reliable The Chemours stock forecast. The Wall Street analysts predict Hold for CC. See at a glance whether NYSE:CC will rise in the future.

$22.28
Forecast 2023
$42.19
Forecast 2025
$44.40
Forecast 2030
Neutral
TopGraphs Quality Ranking
Forecast 2023
$22.28
Forecast 2025
$42.19
Forecast 2030
$44.40
TopGraphs Quality Ranking
Neutral

Company Info

P/E
0.00
Beta
2.02
Price-to-book Ratio
5.58
Market Cap
4.07B
TEV
7.17 B
Dividend
$1.01
Div Yld
3.66%
Forecast 1Y
14.03%
Forecast 2Y
58.92%
Analyst Price Target
$33.22

The Chemours Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

The Chemours Stock Forecast 2023

$30.00

In the last five quarters, The Chemours’s Price Target has fallen from $37.18 to $33.22 - a -10.65% decrease. Two analysts predict that The Chemours’s share price will fall in the coming year, reaching $30.00. This would represent a decrease of -9.69%.

8.34%
8.34
Last update: 04/30/2024

Highest Price Target $40.00

Average Price Target $30.00

Lowest Price Target $26.00

The Chemours Stock Prediction 2025

The Chemours Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $33.64. An increase of 21.49% compared to the previous month's estimate.

The Chemours Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $34.42. An increase of 24.3% compared to the previous month's estimate.

The Chemours Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $35.19. An increase of 27.1% compared to the previous month's estimate.

The Chemours Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $35.97. An increase of 29.91% compared to the previous month's estimate.

The Chemours Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $36.75. An increase of 32.71% compared to the previous month's estimate.

The Chemours Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $37.53. An increase of 35.52% compared to the previous month's estimate.

The Chemours Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $38.30. An increase of 38.32% compared to the previous month's estimate.

The Chemours Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $39.08. An increase of 41.13% compared to the previous month's estimate.

The Chemours Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $39.86. An increase of 43.93% compared to the previous month's estimate.

The Chemours Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $40.63. An increase of 46.74% compared to the previous month's estimate.

The Chemours Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $41.41. An increase of 49.55% compared to the previous month's estimate.

The Chemours Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $42.19. An increase of 52.35% compared to the previous month's estimate.

The Chemours Stock Forecast 2030

Stock Forecast for the Price of an The Chemours Share in Jan 2030.

In January 2030, analysts believe the stock price will be $41.71. An increase of 50.64% compared to the previous month's estimate.

Stock Forecast for the Price of an The Chemours Share in Feb 2030.

In February 2030, analysts believe the stock price will be $41.96. An increase of 51.52% compared to the previous month's estimate.

Stock Forecast for the Price of an The Chemours Share in Mar 2030.

In March 2030, analysts believe the stock price will be $42.20. An increase of 52.4% compared to the previous month's estimate.

Stock Forecast for the Price of an The Chemours Share in Apr 2030.

In April 2030, analysts believe the stock price will be $42.44. An increase of 53.29% compared to the previous month's estimate.

Stock Forecast for the Price of an The Chemours Share in May 2030.

In May 2030, analysts believe the stock price will be $42.69. An increase of 54.17% compared to the previous month's estimate.

Stock Forecast for the Price of an The Chemours Share in Jun 2030.

In June 2030, analysts believe the stock price will be $42.93. An increase of 55.05% compared to the previous month's estimate.

Stock Forecast for the Price of an The Chemours Share in Jul 2030.

In July 2030, analysts believe the stock price will be $43.18. An increase of 55.93% compared to the previous month's estimate.

Stock Forecast for the Price of an The Chemours Share in Aug 2030.

In August 2030, analysts believe the stock price will be $43.42. An increase of 56.81% compared to the previous month's estimate.

Stock Forecast for the Price of an The Chemours Share in Sep 2030.

In September 2030, analysts believe the stock price will be $43.67. An increase of 57.69% compared to the previous month's estimate.

Stock Forecast for the Price of an The Chemours Share in Oct 2030.

In October 2030, analysts believe the stock price will be $43.91. An increase of 58.57% compared to the previous month's estimate.

Stock Forecast for the Price of an The Chemours Share in Nov 2030.

In November 2030, analysts believe the stock price will be $44.15. An increase of 59.46% compared to the previous month's estimate.

Stock Forecast for the Price of an The Chemours Share in Dec 2030.

In December 2030, analysts believe the stock price will be $44.40. An increase of 60.34% compared to the previous month's estimate.

P/E
0.00
Beta
2.02
Price-to-book Ratio
5.58
Market Cap
4.07B
TEV
7.17 B
Dividend
$1.01
Div Yld
3.66%
Forecast 1Y
14.03%
Forecast 2Y
58.92%
Analyst Price Target
$33.22

The Chemours Analyst Ratings Frequently Asked Questions

Who are the analysts watching The Chemours Company?

The following analysts have recently covered The Chemours:

Argus Research Company
Barclays
BMO Capital Markets Equity Research
CFRA Equity Research
Goldman Sachs
J.P. Morgan
Jefferies LLC
Marktfeld
Morgan Stanley
RBC Capital Markets
UBS Investment Bank
S&P Global Ratings
Veritas Investment Research Corp
Baptista Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching The Chemours Company?

The following sell-side analysts have recently covered The Chemours:

Coleman, David E.
Leithead, Michael James
McNulty, John Patrick
Mitsch, Emily Nasseff
Fischer, Patrick Duffy
Alexander, Laurence
Paraskevopoulos, Michail
Andrews, Vincent Stephen
Viswanathan, Arun Shankar
Spector, Joshua David
Terral, Matthew
Liu, Jacob
Zekauskas, Jeffrey John
Majumdar, Ishan
(This information refers to the last 90 days.)